Abstract
Medical tourism (MT), as a global industry, demonstrates steady growth, reaching over USD 100 billion in 2024 and projected to expand to USD 278.2 billion by 2035. This growth is driven by demographic shifts, technological innovations, and the increasing demand for affordable, high-quality healthcare services. The article provides a comprehensive analysis of the competitive position of the Republic of Kazakhstan in this market, based on secondary data from academic publications, statistical reports, relevant sources, and market research on MT. Key strengths have been identified, including Kazakhstan’s leadership within the CIS region, a modern medical infrastructure, price affordability, and the presence of unique JCI-accredited clinics (6 institutions as of 2020, expected to grow to 9 by 2025). However, certain weaknesses are also highlighted, such as legislative gaps, a shortage of high-tech medical services, low international recognition, and absence from global medical rankings (for instance, not being among the Top 5 MT destinations according to Medplaneta.kz in 2025). The methodology is based on a qualitative content analysis of sources published between 2010 and 2025, considering recent trends such as the integration of alternative medicine and participation in international exhibitions. The projected potential for inbound medical tourists could reach up to 200,000 patients by 2030, provided that institutional reform recommendations–such as marketing digitalization and the expansion of accreditation–are effectively implemented.